All In MedTech

Device Trial Radar · NCT05462145

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

549

Planned (sponsor's estimate)

Start

Mar 9, 2023

Primary completion

Mar 2029

Study completion Mar 2029

Sponsor

Lead sponsor
Kardium Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 18, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).

Conditions

  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation

Interventions

  • Globe Pulsed Field SystemDevice

    Ablation and atrial mapping with the Globe Pulsed Field System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effectiveness endpointTime frame: 12 months
  2. Safety endpointTime frame: 7 days

Locations

17 sites in 4 countries. Site status is shown where the registry gives one.

  • Grandview Medical Center

    Birmingham, Alabama

  • St. Bernards Medical Center

    Jonesboro, Arkansas

  • Sutter Health - California Pacific Medical Center

    San Francisco, California

14 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.